Skip to content
Screener

Total debt at other companies

Insulet logo
InsuletPODD
$974.7M-47.6%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$739.25M+64.6%
Embecta Corp. logo
Embecta Corp.EMBC
$1.5B-1.0%
AdaptHealth logo
AdaptHealthAHCO
$2B-4.9%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$2.18B+41.6%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $6.51M.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777

FAQ

What is Beta Bionics's total debt?
Beta Bionics (BBNX) reported total debt of $6.51M in Q2 2026.
How has Beta Bionics's total debt changed year-over-year?
Beta Bionics's total debt decreased by 2.6% year-over-year, from $6.69M to $6.51M.
What is the long-term trend for Beta Bionics's total debt?
Over 2 years (2023 to 2025), Beta Bionics's total debt has grown at a 31.5% compound annual growth rate (CAGR), from $4.22M to $7.3M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about Beta Bionics's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude